Teva Pharmaceuticals USA, Inc: Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b
Read the official notice at FDA (drug) →
Get alerts for Teva Pharmaceuticals
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Teva Pharmaceuticals USA, Inc
- Product
- Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.
- Reason / hazard
- Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA, Puerto Rico and Virgin Islands
- Recall initiated
- 2026-04-06
- Code info
- Lots#: 100067507, 100067508, Exp 07/31/2026
- Product quantity
- 5,101 cartons
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Parsippany
- State
- NJ
- Country
- United States
- Event id
- 98730
Free daily digest + "My products" watchlist